BrainGate Neural Interface for Aphasia

(BG-Aphasia-02 Trial)

LR
Overseen ByLeigh R Hochberg, M.D., Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Leigh R. Hochberg, MD, PhD.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

In this study, the investigators aim to continue the development of a brain-computer interface (BCI) to help restore speech for stroke survivors with agrammatic aphasia, a language disorder that affects the ability to speak.

Are You a Good Fit for This Trial?

This trial is for adults who have lost the ability to speak clearly due to a stroke that caused agrammatic aphasia. Participants should be generally healthy enough for surgery and able to take part in study activities.

Inclusion Criteria

I have partial or complete paralysis in all four limbs.
Prior enrollment in BrainGate2 clinical trial (NCT00912041)
I have been diagnosed with a motor neuron or muscle disorder.

Exclusion Criteria

I am taking steroids or immunosuppressive medicines regularly.
Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses
Other serious disease or disorder that could seriously affect ability to participate in the study

What Are the Treatments Tested in This Trial?

Interventions

  • BrainGate Neural Interface System

Trial Overview

The study is testing the BrainGate Neural Interface System, a brain-computer interface designed to help people with speech loss after stroke communicate again. The device records brain signals and translates them into speech or text.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: BrainGate Neural Interface SystemExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Leigh R. Hochberg, MD, PhD.

Lead Sponsor

Trials
4
Recruited
30+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+